KD Treatment for Super-refractory Status Epilepticus

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(15 sites)

China

The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui

Department of Neurology, Xuanwu Hospital Capital Medical University, Beijing, Beijing Municipality

Fujian Medical University Union Hospital, Fuzhou, Fujian

The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi

Guizhou Provincial People's Hospital, Guiyang, Guizhou

The Second Affiliated Hospital of Hainan Medical University, Haikou, Hainan

The First Hospital of Hebei Medical University, Shijiazhuang, Hebei

The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang

The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan

Chifeng Municipal Hospital, Chifeng, Neimenggu

Qilu Hospital，Shandong University, Jinan, Shandong

The Second Affiliated Hospital of Zhejiang University School of Medicine, Hanzhou, Zhejiang

Beijing Tongren Hospital, Capital Medical University, Beijing

The First Hospital of Jilin University, Jilin

Liaocheng People's Hospital, Liaocheng